Anke Maes

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Niels Vandewalle

Vrije Universiteit Brussel

BELGIUM

View details

Ken Maes

Scientist genetic profiling of cancer

BELGIUM

View details

Damya Laoui

Vrije Universiteit Brussel

BELGIUM

View details

Geert Raes

Vrije Universiteit Brussel

BELGIUM

View details

Ann Massie

Vrije Universiteit Brussel

BELGIUM

View details

Catharina Muylaert

Vrije Universiteit Brussel

BELGIUM

View details

Yanmeng Wang

Vrije Universiteit Brussel

BELGIUM

View details

Sofie Deschoemaeker

Vrije Universiteit Brussel

BELGIUM

View details

Inge Oudaert

Vrije Universiteit Brussel

BELGIUM

View details

Rong Fan

Vrije Universiteit Brussel

BELGIUM

View details

Eline Menu

BELGIUM

View details

Gamze Ates

Vrije Universiteit Brussel

BELGIUM

View details

Philip Vlummens

Vrije Universiteit Brussel

BELGIUM

View details

Lien Ann Van Hemelrijck

Vrije Universiteit Brussel

BELGIUM

View details

Kim De Veirman

Vrije Universiteit Brussel

BELGIUM

View details

Stefaan Verhulst

Karolinska Institutet

SWEDEN

View details

Tu Chenggong

Vrije Universiteit Brussel

BELGIUM

View details

Emma Verheye

Vrije Universiteit Brussel

BELGIUM

View details

Elke De Bruyne

Vrije Universiteit Brussel

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anke Maes

Research Interests

Explore related searches

Contact this professor

Articles (10)

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers

Metabolic cross-talk within the bone marrow milieu

Aberrant DNA methylation in multiple myeloma

System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

Collaborators (19)

Niels Vandewalle

Ken Maes

Damya Laoui

Geert Raes

Ann Massie

Catharina Muylaert

Yanmeng Wang

Sofie Deschoemaeker

Inge Oudaert

Rong Fan

Eline Menu

Gamze Ates

Philip Vlummens

Lien Ann Van Hemelrijck

Kim De Veirman

Stefaan Verhulst

Tu Chenggong

Emma Verheye

Elke De Bruyne

Make your next move.